✦ LIBER ✦

Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancer

✍ Scribed by Creagan, Edward T. ;Fountain, Karen S. ;Frytak, Stephen ;Desanto, Lawrence W. ;Earle, John D.

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 133 KB
Volume: 9
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950090203

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Three patients with locally advanced head and neck squamous cell cancer received concomitant radiation therapy (XRT) and cis‐diamminedichloroplatinum (CDDP). The dose of 6,000 rads was to be administered in two 3,000‐rad courses separated by 3 weeks. The CDDP, 30 mg/m^2^, was to be given intravenously on days 2 and 12 of each half of XRT. We were especially concerned with the occurrence of an abscess in one patient and an abscess with hemorrhage in another. In addition, each patient experienced severe and intractable nausea, vomiting, and a pervasive feeling of ill‐health which seemed out of proportion to that usually observed from either XRT or CDDP alone. If the findings in this pilot study are confirmed, the toxicity of XRT with concurrent CDDP as used in our study may well obviate routine clinical usage.

📜 SIMILAR VOLUMES

Cyclophosphamide, adriamycin, and cis-di

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer

✍ Edward T. Creagan; Thomas R. Fleming; John H. Edmonson; James N. Ingle; John E. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

Doxorubicin, vincristine, and cis-diammi

Doxorubicin, vincristine, and cis-diamminedichloroplatinum (II) therapy in patients with advanced breast cancer

✍ Trump, Donald L. ;Ettinger, David S. ;Abeloff, Martin D. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

## Abstract Preliminary data suggesting synergistic activity of cisplatinum and doxorubicin and the expected poor prognosis of women with breast cancer who progress on treatment with cyclophosphamide, methotrexate and 5‐fluorouracil (CMF), led to a trial of monthly doxorubicin (50 mg/M^2^), vincris

Chemotherapy of advanced head and neck c

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule

✍ Steven E. Vogl; Barry H. Kaplan 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 2 views

Cyclophosphamide, adriamycin, and 24-hou

Cyclophosphamide, adriamycin, and 24-hour infusion of cis-diamminedichloroplatinum (II) in the management of patients with advanced head and neck neoplasms

✍ Creagan, Edward T. ;O'Fallon, Judith R. ;Schutt, Allan J. ;Rubin, Joseph ;Woods, 📂 Article 📅 1984 🏛 Wiley (John Wiley & Sons) ⚖ 481 KB

Twenty-eight patients with measurable or evaluable, regionally advanced or metastatic head and neck cancer received the combination of cyclophosphamide (C), adriamycin (ADR), and a 24-hour infusion of cisdiamminedichloroplatinum (11) (P). Most patients had received extensive prior surgery and radiat

Mitomycin-C, methotrexate, bleomycin and

Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck

✍ Steven E. Vogl; Harvey Lerner; Barry H. Kaplan; Fernando Camacho; James Cinberg; 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 2 views

Planned postradiotherapy neck dissection

Planned postradiotherapy neck dissection in patients with advanced head and neck cancer

✍ Timothy S. Boyd; Paul M. Harari; Scott P. Tannehill; Marta C. Voytovich; Gregory 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Background: Metastatic neck nodes in patients with squamous cell carcinoma of the head and neck are most commonly managed by surgery, radiotherapy, or combined-modality therapy. for combined-modality cases, the sequencing of surgery and radiotherapy is generally guided by which modality is consi